Nucleate
Nucleate Podcast
Nucleate is the new voice for next generation biotech leaders.
Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: nucleate-signal.simplecast.com
Autor
Nucleate
Kategoria
Strona podcastu
Ostatni odcinek
23 cze 2026
Gdzie słuchać?
Podcasty w aplikacji Replaio Radio Już wkrótcePodcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów
Odcinki
Empowering Future Biotech Leaders | Dr. Michelle Hoffmann, CBC 19.03.2025 1:16:33
Follow us https://signal.nucleate.xyz/ Apply to the Entrepreneurial Fellows Program in Chicago with the CBC open from March 20-May 2,2025! https://chicagobiomedicalconsortium.org/awards/entrepreneurial-fellows/ In our latest podcast, hosted by Sam Kessel, Dr. Michelle Hoffmann discusses her unique journey from a PhD in molecular neuroscience PhD to a biotech consultant, and how her experiences sha...
Rewriting Genetic Medicine with Epigenetic Editing | Dr Catherine Stehman-Breen, former CEO of Chroma Medicine 05.03.2025 1:19:35
Follow us on https://signal.nucleate.xyz/ 04:14 - Dr. Stehman-Breen discusses her decision to pursue a career in medicine. 05:49 - Dr. Stehman-Breen explains her specialty choice in internal medicine and nephrology. 08:09 - Skills and mindset that prepared Catherine for a career in industry. 13:53 - The critical impact that physicians can have in biotech 19:03 - Overview of epigenetic editing and...
Revolutionizing Gene Therapy with AI | Eric Kelsic, Dyno Tx 05.02.2025 57:22
Follow us at https://signal.nucleate.xyz/ 02:18 - Eric Kelsic's background in physics and systems biology and how it shaped his approach to biological problems 03:57 - Differences in problem-solving between Kelsic's physics/systems biology background and traditional biology backgrounds 06:27 - Learning from working with George Church and his lab's approach to fostering innovation 10:02 - George Ch...
From Sequencing the Human Genome to Venture Capital | Peter Barrett, Atlas Venture 22.01.2025 1:04:43
Follow us on https://signal.nucleate.xyz/ Peter Barrett discussed his career journey, from starting in a technical role at Perkin Elmer to co-founding Celera Genomics and being part of the team that first sequenced the human genome. He then transitioned to venture capital, joining Atlas Venture, where he has focused on building and investing in innovative therapeutic and drug discovery companies....
Designing Programmable Genetic Medicines | Jake Becraft, Strand Therapeutics 07.01.2025 51:51
Follow the Nucleate Podcast on our website: https://signal.nucleate.xyz/ Jake Becraft, the co-founder and CEO of Strand Therapeutics, discusses his journey from pursuing a PhD in chemical engineering and synthetic biology at MIT to starting a biotech company focused on developing programmable mRNA therapeutics. At MIT, he worked on developing nanoparticles for DNA delivery and became interested in...
The Vagina Business | Marina Gerner 08.12.2024 41:08
The Vagina Business, by Dr Marina Gerner, covers key issues in women's health and the novel solutions in development to address them. The book has already been getting attention with grants from the Alfred P. Sloan Foundation and The Society of Authors. Kirkus Reviews has praised the book as "energetic, thoroughly engaging reading" and emphasized its potential to improve women's health outcomes wo...
The Art of the Pitch: Storytelling in Film and Biotech | Michael Langer, T.Rx Capital 19.11.2024 37:23
00:53 Michael discusses his background and inspirations for pursuing an intersectional career in biotech investing and film-making 6:24 Michael shares about taking time away from college to backpack in places like Fiji and New Zealand, and how that impacted his personal growth 12:43 Michael reflects on his experience at Pear Therapeutics, including lessons learned about business model risk and bri...
Unlocking the power of the gut microbiome with AI | Leo Grady, Jona 03.11.2024 45:12
In this episode, Anastasia Janas interviews Leo Grady, founder and CEO of Jona. With over 20 years in AI and healthcare, Leo has made a profound impact on the field, including leading the development of the first FDA-approved AI system in pathology at Paige. AI. Together, they dive into the journey that led him to create Jona, a company focused on using AI to analyze the gut microbiome for persona...
Biotech journalism & scaling new heights for a good cause | Luke Timmerman, Timmerman Report 20.10.2024 1:00:37
In this episode, Sam Kessel and Anastasia Janas interview Luke Timmerman , an award-winning biotech journalist and founder of the Timmerman Report , as well as host of The Long Run Podcast . They explore Luke's non-traditional background, his curiosity, and his openness to learning, which shaped his journey to becoming a prominent figure in the biotech space. Luke shares insights into his career,...
Patient-Centered Innovation | Irene Blat, Servier 29.09.2024 40:47
In this episode, Sam Kessel speaks with Irene Blat, Senior Director for Search and Evaluation at Servier. Dr Blat discusses her lifelong fascination with science and inspiration to take her Oncology studies to industry to develop new therapies for patients. She discussed the intersection of science and business in Search and Evaluation identifying promising technologies. She talks about the key as...
Fostering Innovation in Biotech | Fiona Mack Bayer Co.Lab 28.08.2024 45:11
0:00 Background and inspiration for pursuing a career in Biotech 5:10 Pivoting from academia to industry 8:30 Growth in industry from a scientist role into business development 16:15 The inspirational mission and vision for Bayer Co-lab to support early stage entrepreneurs 20:30 Fiona’s role at Bayer Co-lab 24:15 Fiona’s advice for entrepreneurs applying for the Co-lab 29:00 Fiona’s view on tren...
Engineering Dendritic Cells to Treat Cancer (Part 2) | Guardian Bio 12.08.2024 37:14
Part 2 Using TikTok to develop scientific communication skills [0:00] Advice for entrepreneurs starting a company [6:00] Guardian's Series A Fundraise and how they are navigating VC Fundraising [10:30] The long-term vision of Guardian Bio for novel cell therapies treating [14:30] The importance of Diversity in Biotech [17:20] Exciting trends in Biotech that Ananya and Ricky are following [25:40] P...
Engineering Dendritic Cells to Treat Cancer (Part 1) | Guardian Bio 12.08.2024 39:54
Origin Stories and path to Biotech [00:00] Taking the leap to entrepreneurship [07:30] The formation story of Guardian Bio [20:25] The methodical process Ananya used to identify a co-founder [26:00] The core thesis of Guardian Bio- Dendritic Cells for Solid Tumors [29:00] The key pivots Guardian made early on [34:15]
Generative AI for Novel Therapies | Sean McClain, Absci 06.05.2024 53:13
Check out Episode 8 of the Nucleate Podcast. We were honored to have Sean McClain, the founder and CEO of AbSci speak about generative AI for developing novel therapies. The potential to accelerate development of therapies for patients is astronomical.
Pioneering Cell Therapy | Bobby Gaspar, Orchard Therapeutics 19.12.2023 47:08
[02:15] Bobby Gaspar’s background [05:10] The science of haematopoietic stem cell therapy [12:30] Spinning out Orchard Therapeutics [21:15] Reverse partnerships with pharma [25:55] Balancing regulatory compliance and innovation [29:45] Value based payments [35:15] Recent approval of Casgevy and gene therapy regulation [39:45] Failures in a biotech’s journey [43:00] Impact and meaning in therapeut...
Building a Search Engine for Chemistry| Lee Cronin, Chemify 19.10.2023 51:16
On this episode of the podcast, Signal hosts Michael Retchin and Ursule Demael interview Prof. Lee Cronin from Chemify. Lee Cronin is a Professor at the University of Glasgow, where he leads a research group focused on digital chemistry, automating chemical synthesis and origin of life. Lee Cronin is also the co-founder and CEO of Chemify, a startup advancing digitization and robotics for chemistr...
Novel CRISPR Systems | Trevor Martin, Mammoth Bio 29.09.2023 35:13
Trevor talks about his inspirations for his career path [1:22] How to choose his PhD advisor and lab [3:51] Career trajectory, handling moments of uncertainty, and learning from mistakes [9:56] Trevor discovered a niche at the intersection of biology, physics, and computer science [11:54] Mammoth is uniquely positioned as an innovative science-focused company that delivers for patients [18:36] Tre...
Building Biotech Ecosystems | Tony Kulesa, Pillar VC 08.09.2023 42:35
Show Notes Tony's career foundations as an academic scientist at MIT and early inspiration for entrepreneurship [0:43] Engaging in entrepreneurial groups shaped Tony's early career [07:10] Tony's inspiration to co-found Petri [11:38] Pillar is rethinking the approach to biotech investing [25:21] Pillar's investment thesis [30:34] Tony's advice to a PhD student who is considering industry and entr...
The Steve Jobs of Biotech | Brian Goodman, MPM Capital 24.07.2023 50:53
What sparked Dr. Goodman’s interest in biotech (0:00) Deciding to pivot from academia to venture capital (3:45) Failing fast and applying that mindset to science (9:44) Transitioning from academia to a start up (14:44) Advice for aspiring technical founders (20:03) Becoming an investor at MPM Capital (30:24) MPM’s investment thesis in oncology. (40:14)
The Beginning of the Microbe Metaverse | Cheri Ackerman, Concerto Biosciences 21.04.2023 40:32
Introducing Nucleate Signal, a celebration of the next generation of biotech leaders. In this episode, host Emmanuella Nnuji-John is joined by guest Cheri Ackerman, the co-founder and CEO of Concerto Bioscience.
Robotics Will Liberate Biotech Creativity | Martin Immanuel-Bittner, Arctoris 21.04.2023 29:50
In this episode, host Jingyi Liu and Sam Kessel are joined by guest Martin-Immanuel Bittner, the co-founder and CEO of Arctoris.
Podobne podcasty
Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS